A massive funding round reveals how independent physicians are using artificial intelligence to survive the shift to risk-based Medicare contracts.

For years, independent medical practices faced a grim choice: sell to a massive hospital network or drown in administrative complexity. The shift toward value-based care—where doctors are paid for patient outcomes rather than the volume of tests—only raised the financial stakes. Small clinics simply lacked the data infrastructure to take on financial risk.

Now, capital is flowing to a third option.

The AI Shield

Pearl Health recently secured $110 million in new funding, including a $50 million equity round led by Andreessen Horowitz and a $60 million debt facility. This is not speculative venture capital for an unprofitable startup. The company reached profitability in 2025.

The capital will expand AI agents designed to orchestrate care and predict performance. These tools allow small clinics to manage the financial risk of Medicare patients without corporate backing. It keeps clinical decision-making local.

Shifting the Power

This funding signal is clear. Wall Street is betting that software, not hospital consolidation, will coordinate modern healthcare. Similar large raises for competitors like Honest Health and Chamber Cardio prove this is a structural shift, not an isolated event.

By automating patient tracking and risk assessment, AI gives independent doctors the analytical power of a major health system. It levels the playing field.

However, the strategy relies on a major assumption. AI must accurately predict patient risks to keep clinics profitable under fixed budgets. If the algorithms miscalculate, small practices will bear the financial pain. The tech must prove it can protect margins, not just manage data.